Food and Drug Administration

Antiviral Drugs Advisory Committee

May 14, 2003

Briefing Information


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Valtrex® (valacyclovir hydrochloride), GlaxoSmithKline (PDF)

Valtrex® (valacyclovir hydrochloride), FDA Review (HTM) (PDF) (Word)